JIROBLI Trademark

Trademark Overview

On Monday, January 12, 2015, a trademark application was filed for JIROBLI with the United States Patent and Trademark Office. The USPTO has given the JIROBLI trademark a serial number of 79162765. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, October 7, 2022. This trademark is owned by Boehringer Ingelheim International GmbH. The JIROBLI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
jirobli

General Information

Serial Number79162765
Word MarkJIROBLI
Filing DateMonday, January 12, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, October 7, 2022
Registration Number4920089
Registration DateTuesday, March 22, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 5, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
Translation of Words in MarkThe wording "JIROBLI" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Monday, July 31, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, July 11, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, July 11, 2023INVALIDATION PROCESSED
Wednesday, June 7, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 7, 2022CANCELLED SECTION 71
Monday, March 22, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 22, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 1, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 1, 2016FINAL DISPOSITION PROCESSED
Wednesday, June 22, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 22, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, January 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2016PUBLISHED FOR OPPOSITION
Monday, January 4, 2016NOTIFICATION PROCESSED BY IB
Wednesday, December 16, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 16, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 16, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 2, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 27, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 27, 2015AMENDMENT FROM APPLICANT ENTERED
Friday, November 27, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 27, 2015NOTICE OF REINSTATEMENT MAILED
Thursday, May 21, 2015REINSTATEMENT GRANTED - RESPONSE RECEIVED
Friday, November 6, 2015ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, November 6, 2015ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, May 28, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 21, 2015ASSIGNED TO LIE
Thursday, May 21, 2015PAPER RECEIVED
Monday, May 11, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, May 2, 2015REFUSAL PROCESSED BY IB
Friday, April 10, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 10, 2015REFUSAL PROCESSED BY MPU
Friday, April 10, 2015APPLICATION FILING RECEIPT MAILED
Wednesday, April 8, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 7, 2015NON-FINAL ACTION WRITTEN
Monday, April 6, 2015ASSIGNED TO EXAMINER
Monday, April 6, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 3, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 2, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

jirobli system pharmaceutical preparations diseases disorders treatment blood nervous peripheral genitourinary